Cargando…

Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial

OBJECTIVES: This study aimed to evaluate the efficacy, adverse events, patient compliance, and cost of dual therapy with Ilaprazole-amoxicillin (IA) at high dose versus Ilaprazole-amoxicillin-furazolidone-bismuth (IAFB) quadruple therapy for the Helicobacter pylori (H.pylori) infection among Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao-Dong, Zhang, Da-Ya, Chen, Run-Xiang, Chen, Shi-Ju, Chen, Chen, Zeng, Fan, Huang, Shi-Mei, Li, Da, Bai, Fei-Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364389/
https://www.ncbi.nlm.nih.gov/pubmed/37488516
http://dx.doi.org/10.1186/s12876-023-02890-5